Literature DB >> 19893425

Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC Trial): a randomized study.

Desmond P J Barton1, Raj Naik, Jonathan Herod.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19893425     DOI： 10.1111/IGC.0b013e3181b89f95

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN： 1048-891X            Impact factor:   3.437


× No keyword cloud information.
  13 in total

Review 1.  What can we learn from oncology surgical trials?

Authors:  Serge Evrard; Pippa McKelvie-Sebileau; Cornelis van de Velde; Bernard Nordlinger; Graeme Poston
Journal:  Nat Rev Clin Oncol       Date:  2015-10-20       Impact factor: 66.675

2.  Serum HE4 is correlated to prognostic factors and survival in patients with endometrial cancer.

Authors:  A Stiekema; Car Lok; C M Korse; W J van Driel; V van der Noort; G G Kenter; K K Van de Vijver
Journal:  Virchows Arch       Date:  2017-04-11       Impact factor: 4.064

3.  Survival benefit of pelvic and paraaortic lymphadenectomy in high-grade endometrial carcinoma: a retrospective population-based cohort analysis.

Authors:  Thomas Papathemelis; S Scharl; K Kronberger; M Gerken; A Scharl; A Pauer; M Klinkhammer-Schalke
Journal:  J Cancer Res Clin Oncol       Date:  2017-08-24       Impact factor: 4.553

4.  Preoperative work-up for definition of lymph node risk involvement in early stage endometrial cancer: 5-year follow-up.

Authors:  Pietro Cignini; Salvatore Giovanni Vitale; Antonio Simone Laganà; Antonio Biondi; Valentina Lucia La Rosa; Giuseppe Cutillo
Journal:  Updates Surg       Date:  2017-01-20

5.  Trends in Sentinel Lymph Node Mapping and Adjuvant Therapy in Endometrial Carcinoma.

Authors:  Natalia R Gómez-Hidalgo; Ling Chen; June Y Hou; Ana I Tergas; Caryn M St Clair; Cande V Ananth; Dawn L Hershman; Jason D Wright
Journal:  Cancer Invest       Date:  2018-03-22       Impact factor: 2.176

Review 6.  The diagnosis and treatment of endometrial cancer: progress and controversies.

Authors:  Dominik Denschlag; Uwe Ulrich; Günter Emons
Journal:  Dtsch Arztebl Int       Date:  2010-08-29       Impact factor: 5.594

Review 7.  [Metastatic mechanisms of uterine malignancies and therapeutic consequences].

Authors:  S F Lax; K F Tamussino; P F Lang
Journal:  Pathologe       Date:  2016-11       Impact factor: 1.011

Review 8.  Lymphadenectomy for the management of endometrial cancer.

Authors:  Jonathan A Frost; Katie E Webster; Andrew Bryant; Jo Morrison
Journal:  Cochrane Database Syst Rev       Date:  2017-10-02

9.  Concordance between preoperative ESMO-ESGO-ESTRO risk classification and final histology in early-stage endometrial cancer.

Authors:  Manon Daix; Martina Aida Angeles; Federico Migliorelli; Athanasios Kakkos; Carlos Martinez Gomez; Katty Delbecque; Eliane Mery; Stéphanie Tock; Erwan Gabiache; Marjolein Decuypere; Frédéric Goffin; Alejandra Martinez; Gwénaël Ferron; Frédéric Kridelka
Journal:  J Gynecol Oncol       Date:  2021-04-05       Impact factor: 4.401

10.  FGFR2 point mutations in 466 endometrioid endometrial tumors: relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological features.

Authors:  Sara A Byron; Michael Gartside; Matthew A Powell; Candice L Wellens; Feng Gao; David G Mutch; Paul J Goodfellow; Pamela M Pollock
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.